INSULIN-LIKE GROWTH-FACTOR-I, INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS, AND GROWTH-HORMONE BINDING-PROTEIN IN SPANISH PREMATURE AND FULL-TERM NEWBORNS
V. Barrios et al., INSULIN-LIKE GROWTH-FACTOR-I, INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS, AND GROWTH-HORMONE BINDING-PROTEIN IN SPANISH PREMATURE AND FULL-TERM NEWBORNS, Hormone research, 46(3), 1996, pp. 130-137
The normal values of insulin-like growth factor I (ICF-I), IGF-binding
proteins 1 and 3 (IGFBP-1 and IGFBP-3), and the high-affinity growth
hormone binding protein (GHBP) are not well established in large serie
s of healthy full-term newborns. We report the normative data for IGF-
I, IGFBP-1, IGFBP-3, and GHBP in 271 normal Spanish full-term newborns
, born between 37 and 42 weeks of gestation, and compare these results
with the same parameters studied in 39 premature infants. Furthermore
, we report the relationship between results found in the normal full-
term newborns and those of 252 healthy prepubertal (Tanner stage I) Sp
anish children. Serum GHBP, IGF-I, and IGFBP-3 levels are very low in
the premature infant and show a significant increase in full-term newb
orns and during childhood (p < 0.001; analysis of variance). In contra
st, the serum IGFBP-1 levels are very high in premature newborns, fall
in full-term newborns, and continue to decline during childhood (p <
0.001; analysis of variance). A positive correlation between GHBP, IGF
-I, and IGFBP-3 versus gestational age was observed. In contrast, we f
ound a negative correlation between IGFBP-1 and gestational age. There
is a direct relationship between the ponderal index and IGF-I and IGF
BP-3. When the group of premature newborns was divided into infants bo
rn before or after 32 weeks of gestation, we found higher levels of IG
F-I and IGFBP-3 (p < 0.01 and p < 0.05, respectively, by Student's t t
est) in the group with the higher gestational age; however, the IGFBP-
1 level was lower in this group (p < 0.001 by Student's t test), with
no differences seen in serum GHBP concentrations. The presence of IGFB
Ps in the premature infant suggests that they are important modulators
of IGF-I action during fetal growth and development.